ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 201863 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 201863; 2) Community: the network communities that were significantly associated with the response to NSC 201863; 3) Molecule: the relationships between components within communities and NSC 201863; 4) MDR: the compounds that were significantly associated with the NSC 201863.

NSC Compound Enrichment Correlation
NSC 674196 Null 0.00888636978630776 0.010980993
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.00888636978630782 -0.077462817
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.00888636978630782 0.33223121
NSC 125066 Bleomycin sulfate 0.0115521552688255 0.33214904
NSC 127128 Null 0.0115521552688255 0.16843137
NSC 182986 AZQ 0.0115521552688255 0.28292364
NSC 276382 PEPLEOMYCIN 0.0115521552688258 0.29604818
NSC 294979 BLEOMYCIN-BAPP 0.0115521552688258 0.29466164
NSC 633530 1H-Pyrido[3,4-b]indol-1-one, 2,3,4,9-tetrahydro-2-[4-(4- phenyl-1-piperazinyl)butyl]-9-methyl- 0.0115521552688258 -0.30341918
NSC 641233 2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- 0.0115521552688258 -0.17314541
Total:46  Current:10    [First] [Prev] [Next] [Last]